Viridian Therapeutics (VRDN) Earnings Date & Reports

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VRDN is expected to report earnings to rise 20.46% to -97 cents per share on May 07

Viridian Therapeutics VRDN Stock Earnings Reports

Q1'25

Est.

$-0.98

Q4'24

Beat

by $0.22

Q3'24

Missed

by $0.09

Q2'24

Missed

by $0.15

Q1'24

Beat

by $0.30

The last earnings report on February 27 showed earnings per share of -81 cents, beating the estimate of -102 cents. With 524.68K shares outstanding, the current market capitalization sits at 1.10B.

View a ticker or compare two or three

Compare

VRDN